SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...
SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...
Adaptive Biotechnologies Corporation announced it will release its second quarter 2025 financial results on August 5, 2025, after market close, followed by a conference call at 1:30 p.m. Pacific Time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results